Journal Report

Blood Advances

Download PDF
Journal Information
Journal Title
Blood Advances
Publisher
American Society of Hematology
ISSN
2473-9529
E-ISSN
2473-9537
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Cytoreduction for MPN-associated splanchnic vein thrombosis
Rohan K. Achar, Jan Philipp Bewersdorf
2026-11-24 Vol. 10 Issue 22 Pages 7543-7544
DOI: 10.1182/bloodadvances.2026022149
Synthetic lethality in <i>TP53</i> -mutated AML
Jeremy T. Baeten, Daniel C. Link
2026-11-24 Vol. 10 Issue 22 Pages 7475-7475
DOI: 10.1182/bloodadvances.2026021344
Factors associated with recurrent episodes of acute chest syndrome in adult patients with sickle cell disease
Geoffrey Cheminet, Eléonore Herquelot, Mallory Cals et al.
2026-11-24 Vol. 10 Issue 22 Pages 7515-7519
DOI: 10.1182/bloodadvances.2026020626
Systematic review and meta-analysis of hypersensitivity reactions after high-dose IV iron
Stephen Divers, Christopher Elder, Patrick C. Foy et al.
2026-11-24 Vol. 10 Issue 22 Pages 7536-7542
DOI: 10.1182/bloodadvances.2026019945
Nonanemic iron deficiency in pregnancy: a cross-sectional study of prevalence and predictors
Sarah Detlefs, Jacquelyn Powers, Charles Minard et al.
2026-11-24 Vol. 10 Issue 22 Pages 7580-7585
DOI: 10.1182/bloodadvances.2026021551
Impact of cytoreductive therapy in myeloproliferative neoplasm–associated splanchnic vein thrombosis
Douglas Tremblay, Amica Ko, Pavlina Chrysafi et al.
2026-11-24 Vol. 10 Issue 22 Pages 7476-7484
DOI: 10.1182/bloodadvances.2026020925
Peripheral CD8+ T-cell clonality and NK-cell expansion mark early response to mosunetuzumab in indolent B-cell lymphoma
Charles J. Milrod, Anna Chorzalska, Dennis Bonal et al.
2026-11-24 Vol. 10 Issue 22 Pages 7558-7570
DOI: 10.1182/bloodadvances.2026021450
Teclistamab and daratumumab immune-based doublet therapy for relapsed/refractory multiple myeloma: the TRIMM-2 study
Paula Rodríguez-Otero, Daniel Morillo, Anita D’Souza et al.
2026-11-24 Vol. 10 Issue 22 Pages 7586-7596
DOI: 10.1182/bloodadvances.2026020648
Age- and sex-adjusted genomic differences between Korean and Beat AML cohorts
Mihee Kim, Ik-Chan Song, Jooheon Park et al.
2026-11-24 Vol. 10 Issue 22 Pages 7520-7524
DOI: 10.1182/bloodadvances.2026020609
Survival improvement of patients with DLBCL treated with third-line and beyond in the recent era in the Czech Republic
Prokop Vodička, Andrea Janíková, Kamila Polgárová et al.
2026-11-24 Vol. 10 Issue 22 Pages 7485-7489
DOI: 10.1182/bloodadvances.2026020000
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 13, 2026 08:52